Free Trial

Karyopharm Therapeutics (KPTI) SEC Filings & 10K Form

Karyopharm Therapeutics logo
$0.77 -0.01 (-0.65%)
(As of 11:30 AM ET)

Recent Karyopharm Therapeutics SEC Filings

DateFilerForm TypeView
11/12/2024
2:50 PM
Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/06/2024
3:06 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
7:02 AM
Karyopharm Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/05/2024
6:47 AM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
6:41 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:49 AM
Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
6:41 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
8:30 AM
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G
09/05/2024
3:28 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:13 PM
Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:24 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:26 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:05 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:31 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
6:33 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:42 AM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
3:14 PM
Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:07 PM
Karyopharm Therapeutics (Subject)
Form SC TO-I/A
07/09/2024
3:15 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
06/20/2024
7:01 AM
Karyopharm Therapeutics (Subject)
Form SC TO-I
06/09/2024
11:15 PM
Karyopharm Therapeutics (Filer)
Form EFFECT
06/07/2024
6:18 PM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:51 PM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
7:00 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:19 PM
BOHLIN GAREN G (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:25 PM
Greene Barry E (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Mirza Mansoor Raza (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Schor Chen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
4:32 PM
Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
3:44 PM
Karyopharm Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/14/2024
3:06 PM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:13 PM
Karyopharm Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:47 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:52 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:56 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
6:55 AM
Karyopharm Therapeutics (Filer)
Form ARS
04/19/2024
6:36 AM
Karyopharm Therapeutics (Filer)
Form DEF 14A
04/19/2024
6:44 AM
Karyopharm Therapeutics (Filer)
Form DEFA14A
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

04/08/2024
4:08 PM
Karyopharm Therapeutics (Subject)
Form SC TO-C
04/08/2024
3:40 PM
Karyopharm Therapeutics (Filer)
Form PRE 14A
04/05/2024
4:20 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:36 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:37 PM
Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:38 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:39 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:40 PM
Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:41 PM
Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:34 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:35 PM
Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:35 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:35 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:35 PM
Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:36 PM
Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
6:43 AM
Karyopharm Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
6:35 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
9:33 AM
Avidity Partners Management LP (Filed by)
Karyopharm Therapeutics (Subject)
Form SC 13G/A
02/12/2024
5:06 AM
Karyopharm Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
02/08/2024
3:36 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:40 PM
Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:43 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:47 PM
Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:53 PM
Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:14 PM
Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:16 PM
Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
12:50 PM
Karyopharm Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/08/2024
8:00 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:40 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:00 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:00 AM
Karyopharm Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2023
4:03 PM
Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KPTI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners